GB0028483D0 - Hydroxyethylamine HIV protease inhibitors - Google Patents
Hydroxyethylamine HIV protease inhibitorsInfo
- Publication number
- GB0028483D0 GB0028483D0 GBGB0028483.6A GB0028483A GB0028483D0 GB 0028483 D0 GB0028483 D0 GB 0028483D0 GB 0028483 A GB0028483 A GB 0028483A GB 0028483 D0 GB0028483 D0 GB 0028483D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydroxyethylamine
- protease inhibitors
- hiv protease
- hiv
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (28)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0028483.6A GB0028483D0 (en) | 2000-11-22 | 2000-11-22 | Hydroxyethylamine HIV protease inhibitors |
| SK760-2003A SK7602003A3 (en) | 2000-11-22 | 2001-11-12 | Novel compounds for use as HIV protease inhibitors |
| CNA018192890A CN1476436A (zh) | 2000-11-22 | 2001-11-12 | 用作hiv蛋白酶抑制剂的新化合物 |
| PCT/EP2001/013068 WO2002042277A1 (en) | 2000-11-22 | 2001-11-12 | Novel compounds for use as hiv protease inhibitors |
| KR10-2003-7006907A KR20030060953A (ko) | 2000-11-22 | 2001-11-12 | Ｈｉｖ 프로테아제 억제제로서 사용하기 위한 신규한 화합물 |
| HU0303007A HUP0303007A2 (hu) | 2000-11-22 | 2001-11-12 | Új vegyületek HIV proteáz inhibitorként történő felhasználásra és a vegyületeket tartalmazó gyógyszerkészítmények |
| CA002428459A CA2428459A1 (en) | 2000-11-22 | 2001-11-12 | Novel compounds for use as hiv protease inhibitors |
| EP01990405A EP1339692A1 (en) | 2000-11-22 | 2001-11-12 | Novel compounds for use as hiv protease inhibitors |
| IL15557301A IL155573A0 (en) | 2000-11-22 | 2001-11-12 | Novel compounds for use as hiv protease inhibitors |
| PL01366704A PL366704A1 (en) | 2000-11-22 | 2001-11-12 | Novel compounds for use as hiv protease inhibitors |
| JP2002544412A JP2004520283A (ja) | 2000-11-22 | 2001-11-12 | Ｈｉｖプロテアーゼインヒビターとして使用するための新規な化合物 |
| AU2002229546A AU2002229546B2 (en) | 2000-11-22 | 2001-11-12 | Novel compounds for use as HIV protease inhibitors |
| NZ525550A NZ525550A (en) | 2000-11-22 | 2001-11-12 | Novel compounds for use as HIV protease inhibitors |
| CZ20031667A CZ20031667A3 (cs) | 2000-11-22 | 2001-11-12 | Nové sloučeniny použitelné jako inhibitory HIV proteázy |
| MXPA03004534A MXPA03004534A (es) | 2000-11-22 | 2001-11-12 | Compuestos novedosos para su uso como inhibidores de la proteasa del virus de inmunodeficiencia humana (vih). |
| AU2954602A AU2954602A (en) | 2000-11-22 | 2001-11-12 | Novel compounds for use as hiv protease inhibitors |
| BR0115566-0A BR0115566A (pt) | 2000-11-22 | 2001-11-12 | Compostos para emprego como inibidores de protease de hiv |
| RU2003117468/04A RU2265016C2 (ru) | 2000-11-22 | 2001-11-12 | Изохинолинкарбоксамиды и лекарственное средство на их основе для применения в качестве ингибиторов протеазы вич |
| US09/999,082 US6472404B1 (en) | 2000-11-22 | 2001-11-20 | HIV protease inhibitors |
| PA20018533401A PA8533401A1 (es) | 2000-11-22 | 2001-11-21 | Inhibidores de la proteasa hidroxietilamina del vih |
| GT200100233A GT200100233A (es) | 2000-11-22 | 2001-11-21 | Nuevos inhibidores de la proteasa de vih. |
| ARP010105431A AR031763A1 (es) | 2000-11-22 | 2001-11-21 | Nuevos compuestos para el uso como inhibidores de proteasas hiv |
| UY27033A UY27033A1 (es) | 2000-11-22 | 2001-11-21 | Nuevos compuestos para su uso como inhibidores de la proteasa de vih |
| PE2001001170A PE20020610A1 (es) | 2000-11-22 | 2001-11-22 | Compuestos hidroxietilamina tripeptidos mimeticos como inhibidores de la aspartil proteasa de vih |
| NO20032290A NO20032290D0 (no) | 2000-11-22 | 2003-05-21 | Nye forbindelser for anvendelse som HIV-protease-inhibitorer |
| EC2003004618A ECSP034618A (es) | 2000-11-22 | 2003-05-21 | Nuevos compuestos para usarse como inhibidores de proteasa vih |
| BG107839A BG107839A (bg) | 2000-11-22 | 2003-05-22 | Нови съединения за използване като hiv протеазни инхибитори |
| MA27172A MA26966A1 (fr) | 2000-11-22 | 2003-05-22 | Nouveaux composes utilisables en tant qu'inhibiteurs de protease hiv |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0028483.6A GB0028483D0 (en) | 2000-11-22 | 2000-11-22 | Hydroxyethylamine HIV protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0028483D0 true GB0028483D0 (en) | 2001-01-10 |
Family
ID=9903670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0028483.6A Ceased GB0028483D0 (en) | 2000-11-22 | 2000-11-22 | Hydroxyethylamine HIV protease inhibitors |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6472404B1 (es) |
| EP (1) | EP1339692A1 (es) |
| JP (1) | JP2004520283A (es) |
| KR (1) | KR20030060953A (es) |
| CN (1) | CN1476436A (es) |
| AR (1) | AR031763A1 (es) |
| AU (2) | AU2954602A (es) |
| BG (1) | BG107839A (es) |
| BR (1) | BR0115566A (es) |
| CA (1) | CA2428459A1 (es) |
| CZ (1) | CZ20031667A3 (es) |
| EC (1) | ECSP034618A (es) |
| GB (1) | GB0028483D0 (es) |
| GT (1) | GT200100233A (es) |
| HU (1) | HUP0303007A2 (es) |
| IL (1) | IL155573A0 (es) |
| MA (1) | MA26966A1 (es) |
| MX (1) | MXPA03004534A (es) |
| NO (1) | NO20032290D0 (es) |
| NZ (1) | NZ525550A (es) |
| PA (1) | PA8533401A1 (es) |
| PE (1) | PE20020610A1 (es) |
| PL (1) | PL366704A1 (es) |
| RU (1) | RU2265016C2 (es) |
| SK (1) | SK7602003A3 (es) |
| UY (1) | UY27033A1 (es) |
| WO (1) | WO2002042277A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101014572B (zh) * | 2004-09-15 | 2011-07-06 | 盐野义制药株式会社 | 具有hiv整合酶抑制活性的氨基甲酰基吡啶酮衍生物 |
| UA87884C2 (uk) * | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
| MY161992A (en) * | 2008-03-26 | 2017-05-31 | Daiichi Sankyo Co Ltd | Novel tetrahydroisoquinoline derivative |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8927913D0 (en) | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
| MX9308016A (es) * | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. |
-
2000
- 2000-11-22 GB GBGB0028483.6A patent/GB0028483D0/en not_active Ceased
-
2001
- 2001-11-12 AU AU2954602A patent/AU2954602A/xx active Pending
- 2001-11-12 NZ NZ525550A patent/NZ525550A/en unknown
- 2001-11-12 JP JP2002544412A patent/JP2004520283A/ja active Pending
- 2001-11-12 AU AU2002229546A patent/AU2002229546B2/en not_active Ceased
- 2001-11-12 BR BR0115566-0A patent/BR0115566A/pt not_active IP Right Cessation
- 2001-11-12 CN CNA018192890A patent/CN1476436A/zh active Pending
- 2001-11-12 WO PCT/EP2001/013068 patent/WO2002042277A1/en active IP Right Grant
- 2001-11-12 HU HU0303007A patent/HUP0303007A2/hu unknown
- 2001-11-12 SK SK760-2003A patent/SK7602003A3/sk unknown
- 2001-11-12 EP EP01990405A patent/EP1339692A1/en not_active Withdrawn
- 2001-11-12 RU RU2003117468/04A patent/RU2265016C2/ru not_active IP Right Cessation
- 2001-11-12 KR KR10-2003-7006907A patent/KR20030060953A/ko not_active Application Discontinuation
- 2001-11-12 CZ CZ20031667A patent/CZ20031667A3/cs unknown
- 2001-11-12 IL IL15557301A patent/IL155573A0/xx unknown
- 2001-11-12 CA CA002428459A patent/CA2428459A1/en not_active Abandoned
- 2001-11-12 PL PL01366704A patent/PL366704A1/xx not_active Application Discontinuation
- 2001-11-12 MX MXPA03004534A patent/MXPA03004534A/es active IP Right Grant
- 2001-11-20 US US09/999,082 patent/US6472404B1/en not_active Expired - Fee Related
- 2001-11-21 GT GT200100233A patent/GT200100233A/es unknown
- 2001-11-21 AR ARP010105431A patent/AR031763A1/es unknown
- 2001-11-21 UY UY27033A patent/UY27033A1/es not_active Application Discontinuation
- 2001-11-21 PA PA20018533401A patent/PA8533401A1/es unknown
- 2001-11-22 PE PE2001001170A patent/PE20020610A1/es not_active Application Discontinuation
-
2003
- 2003-05-21 NO NO20032290A patent/NO20032290D0/no unknown
- 2003-05-21 EC EC2003004618A patent/ECSP034618A/es unknown
- 2003-05-22 BG BG107839A patent/BG107839A/bg unknown
- 2003-05-22 MA MA27172A patent/MA26966A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20032290L (no) | 2003-05-21 |
| BG107839A (bg) | 2004-06-30 |
| NO20032290D0 (no) | 2003-05-21 |
| RU2003117468A (ru) | 2005-01-27 |
| BR0115566A (pt) | 2003-09-30 |
| MXPA03004534A (es) | 2003-09-10 |
| RU2265016C2 (ru) | 2005-11-27 |
| GT200100233A (es) | 2002-07-04 |
| EP1339692A1 (en) | 2003-09-03 |
| AR031763A1 (es) | 2003-10-01 |
| CZ20031667A3 (cs) | 2004-01-14 |
| PA8533401A1 (es) | 2002-10-31 |
| WO2002042277A1 (en) | 2002-05-30 |
| CA2428459A1 (en) | 2002-05-30 |
| SK7602003A3 (en) | 2004-01-08 |
| HUP0303007A2 (hu) | 2003-12-29 |
| MA26966A1 (fr) | 2004-12-20 |
| KR20030060953A (ko) | 2003-07-16 |
| AU2954602A (en) | 2002-06-03 |
| PE20020610A1 (es) | 2002-07-13 |
| ECSP034618A (es) | 2003-06-25 |
| JP2004520283A (ja) | 2004-07-08 |
| CN1476436A (zh) | 2004-02-18 |
| PL366704A1 (en) | 2005-02-07 |
| US6472404B1 (en) | 2002-10-29 |
| NZ525550A (en) | 2004-11-26 |
| IL155573A0 (en) | 2003-11-23 |
| AU2002229546B2 (en) | 2006-05-04 |
| UY27033A1 (es) | 2002-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4344101A (en) | Protease inhibitors | |
| GB0125445D0 (en) | Protease Inhibitors | |
| AU2001247589A1 (en) | Non-amidine containing protease inhibitors | |
| IL153421A0 (en) | Protease inhibitors | |
| IL151087A0 (en) | Protease inhibitors | |
| AU2002360673A8 (en) | Gp41 inhibitor | |
| EP1229912A4 (en) | PROTEASE INHIBITORS | |
| EP1229914A4 (en) | PROTEASE INHIBITORS | |
| EP1173429A4 (en) | PROTEASE INHIBITORS | |
| EP1229911A4 (en) | PROTEASE INHIBITORS | |
| EP1161237A4 (en) | PROTEASE INHIBITORS | |
| EP1401453A4 (en) | PROTEASE INHIBITORS | |
| IL155961A0 (en) | Cysteine protease inhibitors | |
| GB0028483D0 (en) | Hydroxyethylamine HIV protease inhibitors | |
| IL155997A0 (en) | Protease inhibitors | |
| GB0123467D0 (en) | Carbocyclic HIV Protease inhibitors | |
| AU6407701A (en) | Serine protease inhibitors | |
| AU2003287325A8 (en) | N-cycloalkylglycines as hiv protease inhibitors | |
| GB0009123D0 (en) | Protease inhibitor | |
| AU2002255485A8 (en) | Hiv/fiv protease inhibitors | |
| ZA200207478B (en) | Protease inhibitors. | |
| AU2001296247A1 (en) | Cysteine protease inhibitors | |
| IL160626A0 (en) | Antiviral protease inhibitors | |
| AU2001244658A1 (en) | Gamma-secretase-like protease inhibitors | |
| GB0028863D0 (en) | Protease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |